wellrank.ai
Provera logo

Provera

First cited by AI Jun 11, 2026
provera.com.tr

Surfaced organically in AI answers about menopause and women's health. Not yet profiled.

AI Visibility

Visibility trend

Menopause and women's health, daily share of AI answers mentioning Provera, through Jun 13, 2026.

16.7%

Avg position when mentioned: 7.0

By engine

Where Provera is strong, and where it is invisible.

  • ChatGPT
    33.3%
  • Google AI
    33.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 0 positive mentions
  • 3 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Provera

ChatGPTJun 13, 2026, 11:06 UTC
Bioidentical hormones vs standard HRT: what is the difference?

Short answer “Bioidentical” hormones are molecules formulated to be chemically identical to the hormones your body makes (usually estradiol and progesterone). “Standard” HRT (hormone replacement therapy) includes both bioidentical (FDA‑approved) products and older synthetic or animal‑derived products; the main practical difference most people face is whether the product is an FDA‑reviewed drug or a custom‑compounded preparation from a pharmacy. There’s no good evidence that custom‑compounded “bioidentical hormone therapy” is safer or more effective than FDA‑approved HRT. Compounded products can have variable potency and lack FDA oversight. What each term means Bioidentical hormones: chemically identical to human hormones (example: 17β‑estradiol, micronized progesterone). These can be made as FDA‑approved products (tablets, patches, gels, vaginal rings) or as custom compounds from compounding pharmacies. Standard HRT: a broader category that includes FDA‑approved estradiol products (patches, gels, pills) and FDA‑approved micronized progesterone, synthetic progestins (e.g., medroxyprogesterone acetate) and animal‑derived estrogens (e.g., conjugated equine estrogens). These are manufactured drugs with standardized dosing and safety testing. Examples (brand names and why they matter) FDA‑approved, bioidentical examples: Prometrium (micronized progesterone) — FDA‑approved bioidentical progesterone used to protect the uterus when systemic estrogen is given. Estradiol patches/gels: Vivelle‑Dot, Climara, Alora — deliver 17β‑estradiol transdermally and have standardized dosing. Bijuva — an FDA‑approved combined oral capsule containing estradiol and progesterone (bioidentical combination). Vaginal products: Estrace cream, Vagifem tablets, Estring/Femring (vaginal ring/locally acting estradiol) — useful for local symptoms with lower systemic exposure. Non‑bioidentical / synthetic examples: Premarin (conjugated equine estrogens) — animal‑derived estrogen mixture, historically common. Provera (medroxyprogesterone acetate) — synthetic progestin. Compounded “bioidentical” creams or troches: made by compounding pharmacies to a custom dose. These are not FDA‑approved and product strength/purity can vary. If you choose this route, use a PCAB‑accredited compounding pharmacy (look up PCAB accreditation). Examples of well‑known compounding suppliers/pharmacies in the U.S. include Wedgewood Pharmacy and Fagron (as suppliers/compounding networks) — but check current accreditation and reputation locally. Safety, evidence, and regulation FDA‑approved HRT products have known dosages, standardized manufacturing, and have been evaluated for quality and safety. Long‑term risks (breast cancer, cardiovascular disease, stroke, blood clots) depend on the type of hormone, dose, route (oral vs transdermal), whether progesterone is given, and your personal risk factors. The Women’s Health Initiative (WHI) showed increased risks with combined conjugated equine estrogen + medroxyprogesterone in older participants. Risk profiles differ with estradiol vs conjugated equine estrogens and with micronized progesterone vs synthetic progestins. Compounded bioidenticals: proponents claim “natural” = safer, but there’s no high‑quality evidence that compounded BHRT reduces long‑term risks. Because compounded products aren’t FDA‑reviewed, potency and purity can be inconsistent and they may lack safety data. Testing and monitoring Beware of clinics that base dosing on saliva tests or single spot hormone levels — hormone levels fluctuate and those tests are not reliable for routine dosing. Appropriate approach: evaluate symptoms, medical history, family history (breast cancer, clotting disorders), baseline screening (mammogram, blood pressure, lipids, glucose as needed), then choose a therapy and monitor symptoms and side effects regularly. Use the lowest effective dose for the shortest needed time, and use uterine protection (progesterone or a progestin) if you have a uterus and take systemic estrogen. Practical guidance / when to prefer one option If you want the assurance of standardized dosing and known safety data, choose FDA‑approved products (e.g., estradiol patches, oral estradiol, Prometrium, Bijuva). Consider local vaginal estrogen (Estrace cream, Vagifem, Estring) for primarily vaginal dryness/urginal symptoms — these have lower systemic exposure. If you have unusual needs (allergies to excipients, very specific dose requests), a compounding pharmacy can be considered — but insist on a reputable, PCAB‑accredited pharmacy and understand the tradeoffs (no FDA approval, variable evidence). Discuss the choice with a clinician experienced in menopause/HRT care (board‑certified gynecologist or endocrinologist). Trusted resources: North American Menopause Society (NAMS), Mayo Clinic, Cleveland Clinic for patient information and evidence‑based guidance. Bottom line “Bioidentical” describes the molecular structure of the hormone; the clinically important distinction is whether the product is an FDA‑approved, standardized medication or a custom, non‑FDA‑regulated compounded product. FDA‑approved bioidentical options (Prometrium, estradiol patches/creams, Bijuva) give predictable dosing and safety data; compounded BHRT may be useful in select cases but carries more uncertainty. Talk with a clinician about your symptoms, risks, and monitoring plan before starting HRT.

Mentioned in position 11 of 13

Read full answer with sources →
Google AIJun 13, 2026, 11:05 UTC
Bioidentical hormones vs standard HRT: what is the difference?

When discussing bioidentical hormones versus standard Hormone Replacement Therapy (HRT), it's important to understand the core differences and what might be suitable for different individuals. Standard Hormone Replacement Therapy (HRT) typically refers to conventional HRT medications that are synthesized in a lab. These hormones are structurally similar to human hormones, but they may not be chemically identical. They are often derived from animal sources, such as pregnant mare's urine (for conjugated equine estrogens). Bioidentical Hormone Replacement Therapy (BHRT) uses hormones that are chemically identical to those produced by the human body. They are typically plant-derived and then chemically processed in a lab to match human hormones precisely. This means their molecular structure is exactly the same as the hormones your body naturally produces. Here's a breakdown of the key differences: Source and Structure: Standard HRT: Often uses hormones that are similar but not identical to human hormones. Some common examples include conjugated equine estrogens (like in Premarin) and synthetic progestins (like medroxyprogesterone acetate). BHRT: Uses hormones that are molecularly identical to human hormones. These are often derived from soy or yams. Examples include estradiol, estrone, and progesterone that are identical in structure to human hormones. Absorption and Metabolism: Standard HRT: Because the molecular structure might differ slightly, the body may process them differently than its own hormones. Synthetic progestins, for instance, can have different effects on the body compared to natural progesterone. BHRT: Since the hormones are identical to human hormones, they are believed to be metabolized by the body in the same way as endogenous hormones. This can potentially lead to a more natural and targeted effect. Customization: Standard HRT: Available in fixed doses and formulations. While there are various options, they are not typically compounded to individual needs. BHRT: Often available through compounding pharmacies. This allows healthcare providers to create custom formulations with specific dosages tailored to an individual's unique hormone levels and symptoms. Availability: Standard HRT: Widely available as FDA-approved prescription medications from major pharmaceutical companies. Brands like Premarin, Estrace (for estrogen), and Provera (for progesterone) are common examples. BHRT: Can be obtained through prescription from compounding pharmacies. While some bioidentical hormones are available as FDA-approved medications (e.g., Estradiol patches like Estraderm, or vaginal estrogen creams), the compounded versions are often what people refer to when discussing BHRT for systemic use. Why might someone choose one over the other? BHRT is often chosen by individuals seeking a more "natural" approach, believing that hormones identical to their own will be better tolerated and have fewer side effects. The ability to customize dosages is also a significant draw for many. Standard HRT is chosen for its established track record, wide availability, and often lower cost compared to compounded BHRT. The FDA approval for these medications means they have undergone rigorous testing for safety and efficacy. Important Considerations: Consult a Healthcare Professional: The decision between standard HRT and BHRT should always be made in consultation with a qualified healthcare provider. They can assess your individual health needs, symptoms, and risks, and recommend the most appropriate treatment plan. Evidence: While BHRT is popular, it's important to note that the scientific evidence supporting its superiority over standard HRT for all outcomes is still evolving. For many aspects of HRT, the research on FDA-approved standard HRT is more extensive. Compounding Pharmacies: If you opt for BHRT, ensure you are using a reputable compounding pharmacy that adheres to high-quality standards. In summary, the key difference lies in the molecular structure of the hormones used. BHRT uses hormones that are identical to human hormones, while standard HRT uses hormones that may be similar but not identical. Both have their pros and cons, and the best choice depends on individual needs and medical advice.

Mentioned in position 3 of 4

Read full answer with sources →
ChatGPTJun 11, 2026, 20:08 UTC
I am 47 with hot flashes and terrible sleep. What are my treatment options?

Short answer If your hot flashes are frequent/intense and they’re what’s wrecking your sleep, menopausal hormone therapy (MHT, i.e., estrogen ± a progestogen) is the single most effective treatment for both vasomotor symptoms and the sleep problems they cause — provided you don’t have contraindications. If you can’t or don’t want hormones, there are effective non‑hormonal drug and behavioral options (antidepressants, gabapentin, CBT‑I, cooling strategies, etc.). Below is a practical, clinician‑friendly summary of options, pros/cons, and specific products/brands to discuss with your doctor. 1) Menopausal hormone therapy (MHT) — most effective What it treats: Hot flashes, night sweats, and related sleep disruption; it often improves mood and vaginal symptoms as well. Who it’s best for: Generally recommended for women with moderate–severe vasomotor symptoms without major contraindications (history of breast cancer, active liver disease, known clotting disorders, recent stroke/heart attack). Regimens/routes: Systemic estrogen (works best for hot flashes): oral (Estrace, Premarin) or transdermal patch/gel. Transdermal estradiol patches/gels (Vivelle‑Dot, Climara, EstroGel) may have lower risk of blood clots than oral estrogen and are often preferred if you have migraine with aura or higher clot risk. If you have a uterus, you also need a progestogen to protect the lining of the uterus: micronized progesterone (Prometrium) or medroxyprogesterone (Provera) are common. Another option is an intrauterine levonorgestrel device (Mirena) for local progestin. Risks: small increased risks of breast cancer with long‑term combined use, and of VTE/stroke (risk varies by age, time since menopause, route of administration). Use the lowest effective dose for the shortest period needed; many women use it for several years with regular re‑evaluation. 2) Non‑hormonal prescription options (if hormones aren’t appropriate or desired) SSRIs/SNRIs: Paroxetine 7.5 mg (Brisdelle) is FDA‑approved for hot flashes. Note: paroxetine and fluoxetine strongly inhibit CYP2D6 and can interfere with tamoxifen — avoid if you’re taking tamoxifen. Venlafaxine (Effexor) and desvenlafaxine are commonly used and effective for hot flashes; can improve sleep in some women. Gabapentin (Neurontin): often used at bedtime (typical effective total daily doses 300–900 mg) and especially helpful for nighttime hot flashes and sleep. Pregabalin (Lyrica) also effective but is a controlled medication and typically considered after others. Clonidine (Catapres): modest benefit, sometimes used if other options fail. Choice depends on comorbidities (anxiety, depression, insomnia), side‑effect profile, and drug interactions. 3) Treatments targeted primarily at sleep Cognitive behavioral therapy for insomnia (CBT‑I) is first‑line for chronic insomnia and effective long term. Digital programs (e.g., Sleepio) or a behavioral sleep specialist are options. Sleep medications for short‑term use: zolpidem (Ambien) or zaleplon; low‑dose doxepin (Silenor) or trazodone are alternatives; ramelteon (Rozerem) is a melatonin receptor agonist. Avoid chronic benzodiazepine/Z‑drug use if possible. Melatonin (over the counter) can help some people with sleep onset. 4) Lifestyle, behavioral, and practical measures Identify and avoid hot‑flash triggers (alcohol, spicy foods, caffeine, hot rooms). Dress in layers, use fans, keep bedroom cool, moisture‑wicking sleepwear/bedding. Nighttime cooling options: bedside fan, cooling mattress pads/pillows, breathable sheets. Exercise regularly (not right before bed), maintain good sleep hygiene, practice relaxation/breathing techniques for nighttime awakenings. Some women benefit from paced breathing, mindfulness, or CBT for menopausal symptoms. 5) Complementary/alternative interventions — limited evidence Soy/phytoestrogens, black cohosh, and other supplements show mixed results; black cohosh has safety concerns (rare liver toxicity). Discuss before use. Acupuncture has mixed evidence but helps some women. 6) How to choose and what to tell your clinician Important medical history that changes recommendations: breast cancer, history of blood clots or stroke, heart disease, liver disease, migraine with aura, current medications (especially tamoxifen). If you have a uterus and want systemic estrogen, you’ll need progestogen as well (or an IUD). If you had a hysterectomy, estrogen alone is an option. At age 47 you may be perimenopausal (cycles irregular) — this is common; labs (FSH, estradiol) are rarely required unless the diagnosis is unclear. If hot flashes and sleep problems are severe, a primary care doctor or gynecologist can prescribe MHT or a non‑hormonal medication; consider referral to a menopause specialist if complex. Next steps I can help with If you want, tell me: do you still have periods? Any history of breast cancer, blood clots, stroke, heart disease, or migraines with aura? Any current medications (especially tamoxifen) or sleep medications? With that I can suggest a targeted regimen (e.g., a transdermal estradiol patch + micronized progesterone vs. venlafaxine vs. gabapentin) and pros/cons for you.

Mentioned in position 7 of 17

Read full answer with sources →

Public AI visibility history

Daily rank of Provera on our buyer intent questions, per category. A dash means the engines did not cite Provera at all that day. This record is permanent.

CategoryJun 11Jun 12Jun 13
Menopause and women's health#34#10

TL;DR

Provera is a well-known brand name for medroxyprogesterone acetate, a synthetic progestogen manufactured by Pfizer and widely prescribed for menstrual disorders, hormone therapy, and related women's health conditions. The brand operates a Turkish-market web presence at provera.com.tr, reflecting its availability across multiple international markets. In WellRank's latest AI-answer index, Provera ranks fourth in the Menopause and women's health category with 17% visibility, and all three of its tracked AI mentions carry a neutral tone, suggesting it is referenced as a clinical option rather than a recommended or cautioned product.

Company Overview

Provera is a branded pharmaceutical product originally developed by Upjohn and now marketed by Pfizer following successive corporate mergers. It is not an independent company but rather a prescription drug brand sold through pharmacy channels globally. The business model is a traditional pharmaceutical one: the active molecule is available both as the branded Provera and as generic medroxyprogesterone acetate, with revenue flowing through prescriptions filled at licensed pharmacies.

Product Features

  • Oral medroxyprogesterone acetate tablets in multiple dosage strengths
  • Indicated for secondary amenorrhea and abnormal uterine bleeding
  • Used as the progestogen component in combined hormone replacement therapy
  • Available as part of endometriosis management protocols
  • Prescribed for certain cases of endometrial hyperplasia prevention

Target Market

Provera primarily serves women of reproductive age experiencing menstrual irregularities and perimenopausal or postmenopausal women requiring progestogen supplementation alongside estrogen therapy. It is prescribed by gynecologists and primary care physicians across North America, Europe, and markets such as Turkey where provera.com.tr is directed. The brand is relevant wherever synthetic progestogens are part of standard women's health guidelines.

Buyer Personas

  • A perimenopausal woman in her late 40s whose gynecologist has prescribed a progestogen to balance estrogen therapy and reduce endometrial risk.
  • A younger woman with secondary amenorrhea or polycystic ovary syndrome who needs a course of progestogen to regulate her cycle.
  • A postmenopausal woman on combined hormone replacement therapy who fills a monthly prescription at a community pharmacy.
  • A gynecologist or general practitioner researching progestogen options for patients with hormonally driven conditions such as endometriosis or endometrial hyperplasia.

Funding & Performance

Provera is a branded product of Pfizer, a publicly traded company listed on the New York Stock Exchange. Specific revenue attribution to the Provera brand alone is not publicly disclosed as a separate line item in Pfizer's financial reporting.

Recent Developments

Generic medroxyprogesterone acetate has become widely available in most markets, which has shifted prescribing patterns and reduced branded Provera's market share over time. Pfizer continues to maintain the brand in markets where it retains commercial or regulatory significance, including Turkey. Broader industry discussion around the Women's Health Initiative findings from earlier decades continues to shape how clinicians and patients approach progestogen-containing hormone therapy, keeping Provera in ongoing clinical conversations.

Competitive Landscape

According to WellRank co-mention data, AI engines most frequently discuss Provera alongside Premarin, Estrace, Vivelle-Dot, Prometrium, Climara, Wedgewood Pharmacy, Vagifem, and Sleepio, reflecting a competitive set that spans estrogens, progestogens, transdermal systems, and compounding pharmacies. Its most direct competitors for the progestogen-specific indication are Prometrium, a bioidentical progesterone, and generic medroxyprogesterone acetate. The broader menopause category competitors such as Climara and Vivelle-Dot address the estrogen side of combined therapy, meaning Provera often appears in combination discussions rather than head-to-head comparisons.

Provera vs the brands AI recommends alongside it

The real competitive set in Menopause and women's health: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Provera logo
ProveraThis brand
#10
16.7%
Estrace logo
Estrace

3 shared answers

#8
16.7%
Premarin logo
Premarin

3 shared answers

#3
25.0%
Climara logo
Climara

2 shared answers

#7
16.7%
Prometrium logo
Prometrium

2 shared answers

#9
16.7%

Email me when overtakes Provera

One email the day the ranks flip. Nothing else.

User Sentiment

WellRank's corpus shows that all three tracked AI mentions of Provera carry a neutral tone, with zero positive and zero cautious or mixed mentions. This pattern is consistent with how AI engines tend to handle prescription pharmaceutical brands: citing them as factual clinical options within a category rather than endorsing or warning against them. Public patient sentiment found on health forums is more varied and includes both positive reports of cycle regulation and longstanding concerns about side effect profiles, particularly in the context of long-term hormone therapy.

Pricing

Provera is a prescription product and pricing varies significantly by market, insurance coverage, and whether a patient receives the branded tablet or a generic equivalent. Specific retail or out-of-pocket prices are not published by the manufacturer and differ across geographies and pharmacy benefit structures.

Sources cited around Provera

The sites engines cite in answers mentioning this brand. Win these, win the answer.

    Track Provera weekly

    One email a week: rank moves, new competitors, and the answers that changed. No noise.

    Work at Provera? Get your AI Visibility Audit.

    See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.